|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 493/22 | |
| A61K 31/365 | |||
| A61P 33/00 |
| (11) | Number of the document | 2785719 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12798570.3 |
| Date of filing the European patent application | 2012-11-30 | |
| (97) | Date of publication of the European application | 2014-10-08 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/067215 |
| Date | 2012-11-30 |
| (87) | Number | WO 2013/082373 |
| Date | 2013-06-06 |
| (30) | Number | Date | Country code |
| 201161566336 P | 2011-12-02 | US |
| (72) |
CADY, Susan, Mancini, US
MA, Baoqing, US
CHAPMAN, Robert, Clark, US
YANG, Chunhua, US
JAIN, Uday, US
|
| (73) |
Merial, Inc.,
3239 Satellite Boulevard Bldg. 500, Duluth, GA 30096,
US
|
| (54) | LONG-ACTING INJECTABLE MOXIDECTIN FORMULATIONS AND NOVEL MOXIDECTIN CRYSTAL FORMS |
| LONG-ACTING INJECTABLE MOXIDECTIN FORMULATIONS AND NOVEL MOXIDECTIN CRYSTAL FORMS |